Articles in Category: Products, Services & Guidelines

Somaxon Inc. retains exclusivity for insomnia drug till 2020

on Wednesday, 18 July 2012. Posted in Latest Medical Products, Products, Services & Guidelines Written By: HealthTzars News Group

Somaxon Inc retains exclusivity for insomnia drug till 2020: Report

Somaxon Inc. retains exclusivity for insomnia drug till 2020

Reports confirm, drug-maker Somaxon Pharmaceuticals Inc., will retain market exclusivity for its insomnia drug, till 2020. This follows settlement of separate lawsuits with the companies, Mylan Pharmaceuticals and Par Pharmaceuticals Inc.